Gilead Sciences (GILD) Tops Q2 EPS by 10c, Revises FY Guidance
Tweet Send to a Friend
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.82, $0.10 better than the analyst estimate of $1.72. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
